Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations

Inflammatory bowel disease increases the risk of hepatobiliary pancreatic cancer: A two‐sample Mendelian randomization analysis of European and East Asian populations

Abstract Background Both inflammatory bowel disease (IBD) and hepato‐pancreato‐biliary cancers (HPBC) have been established to cause a huge socioeconomic burden. Epidemiological studies have revealed a close association between IBD and HPBC. Methods Herein, we utilized inverse‐variance weighting to...

Full description

Bibliographic Details
Main Authors: Jinsheng Huang, Xujia Li, Jicheng Hong, Lingli Huang, Qi Jiang, Shunqi Guo, Yuming Rong, Guifang Guo
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Cancer Medicine
Subjects:
Crohn's disease
hepatobiliary pancreatic cancer
inflammatory bowel disease
Mendelian randomization
ulcerative colitis
Online Access:https://doi.org/10.1002/cam4.6057

Internet

https://doi.org/10.1002/cam4.6057

Similar Items